An evidence-based treatment algorithm for colorectal polyp cancers: results from the Scottish Screen-detected Polyp Cancer Study (SSPoCS)

ObjectivesColorectal polyp cancers present clinicians with a treatment dilemma. Decisions regarding whether to offer segmental resection or endoscopic surveillance are often taken without reference to good quality evidence. The aim of this study was to develop a treatment algorithm for patients with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gut 2018-02, Vol.67 (2), p.299-306
Hauptverfasser: Richards, CH, Ventham, NT, Mansouri, D, Wilson, M, Ramsay, G, Mackay, CD, Parnaby, CN, Smith, D, On, J, Speake, D, McFarlane, G, Neo, YN, Aitken, E, Forrest, C, Knight, K, McKay, A, Nair, H, Mulholland, C, Robertson, JH, Carey, FA, Steele, RJC
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 306
container_issue 2
container_start_page 299
container_title Gut
container_volume 67
creator Richards, CH
Ventham, NT
Mansouri, D
Wilson, M
Ramsay, G
Mackay, CD
Parnaby, CN
Smith, D
On, J
Speake, D
McFarlane, G
Neo, YN
Aitken, E
Forrest, C
Knight, K
McKay, A
Nair, H
Mulholland, C
Robertson, JH
Carey, FA
Steele, RJC
description ObjectivesColorectal polyp cancers present clinicians with a treatment dilemma. Decisions regarding whether to offer segmental resection or endoscopic surveillance are often taken without reference to good quality evidence. The aim of this study was to develop a treatment algorithm for patients with screen-detected polyp cancers.DesignThis national cohort study included all patients with a polyp cancer identified through the Scottish Bowel Screening Programme between 2000 and 2012. Multivariate regression analysis was used to assess the impact of clinical, endoscopic and pathological variables on the rate of adverse events (residual tumour in patients undergoing segmental resection or cancer-related death or disease recurrence in any patient). These data were used to develop a clinically relevant treatment algorithm.Results485 patients with polyp cancers were included. 186/485 (38%) underwent segmental resection and residual tumour was identified in 41/186 (22%). The only factor associated with an increased risk of residual tumour in the bowel wall was incomplete excision of the original polyp (OR 5.61, p=0.001), while only lymphovascular invasion was associated with an increased risk of lymph node metastases (OR 5.95, p=0.002). When patients undergoing segmental resection or endoscopic surveillance were considered together, the risk of adverse events was significantly higher in patients with incomplete excision (OR 10.23, p
doi_str_mv 10.1136/gutjnl-2016-312201
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835003469</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1835003469</sourcerecordid><originalsourceid>FETCH-LOGICAL-b413t-3137a5f0f85715a85508051af38b971cd7f6d2655bfffe36b15808cc10f2bedb3</originalsourceid><addsrcrecordid>eNqNkcFu1DAQhi1ERbeFF-CALHEphxQ7jmOHW7WCFqkSlQJny3bG3ayceLEdpH0E3hq3aTlw4jRz-L5fM_oRekvJJaWs_Xi_5P3sq5rQtmK0LvMF2tCmlRWrpXyJNoRQUXHRdKfoLKU9IUTKjr5Cp7UQsmu53KDfVzOGX-MAs4XK6AQDzhF0nmDOWPv7EMe8m7ALEdvgQwSbtceH4I8HbHWRYvqEI6TF54RdDBPOO8C9DTmPaVeWCDBXA-Qiluy7R3H7KOI-L8MRX_T9Xdj2H16jE6d9gjdP8xz9-PL5-_amuv12_XV7dVuZhrJcHmVCc0ec5IJyLTknknCqHZOmE9QOwrVD3XJunHPAWkO5JNJaSlxtYDDsHF2suYcYfi6QsprGZMF7PUNYkqKScUJY03YFff8Pug9LnMt1qiaNJIJ3jBWqXikbQ0oRnDrEcdLxqChRD0WptSj1UJRaiyrSu6foxUww_FWemylAtQJm2v9P4B9-TZ9F</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2048075933</pqid></control><display><type>article</type><title>An evidence-based treatment algorithm for colorectal polyp cancers: results from the Scottish Screen-detected Polyp Cancer Study (SSPoCS)</title><source>PubMed Central</source><creator>Richards, CH ; Ventham, NT ; Mansouri, D ; Wilson, M ; Ramsay, G ; Mackay, CD ; Parnaby, CN ; Smith, D ; On, J ; Speake, D ; McFarlane, G ; Neo, YN ; Aitken, E ; Forrest, C ; Knight, K ; McKay, A ; Nair, H ; Mulholland, C ; Robertson, JH ; Carey, FA ; Steele, RJC</creator><creatorcontrib>Richards, CH ; Ventham, NT ; Mansouri, D ; Wilson, M ; Ramsay, G ; Mackay, CD ; Parnaby, CN ; Smith, D ; On, J ; Speake, D ; McFarlane, G ; Neo, YN ; Aitken, E ; Forrest, C ; Knight, K ; McKay, A ; Nair, H ; Mulholland, C ; Robertson, JH ; Carey, FA ; Steele, RJC ; Scottish Surgical Research Group</creatorcontrib><description>ObjectivesColorectal polyp cancers present clinicians with a treatment dilemma. Decisions regarding whether to offer segmental resection or endoscopic surveillance are often taken without reference to good quality evidence. The aim of this study was to develop a treatment algorithm for patients with screen-detected polyp cancers.DesignThis national cohort study included all patients with a polyp cancer identified through the Scottish Bowel Screening Programme between 2000 and 2012. Multivariate regression analysis was used to assess the impact of clinical, endoscopic and pathological variables on the rate of adverse events (residual tumour in patients undergoing segmental resection or cancer-related death or disease recurrence in any patient). These data were used to develop a clinically relevant treatment algorithm.Results485 patients with polyp cancers were included. 186/485 (38%) underwent segmental resection and residual tumour was identified in 41/186 (22%). The only factor associated with an increased risk of residual tumour in the bowel wall was incomplete excision of the original polyp (OR 5.61, p=0.001), while only lymphovascular invasion was associated with an increased risk of lymph node metastases (OR 5.95, p=0.002). When patients undergoing segmental resection or endoscopic surveillance were considered together, the risk of adverse events was significantly higher in patients with incomplete excision (OR 10.23, p&lt;0.001) or lymphovascular invasion (OR 2.65, p=0.023).ConclusionA policy of surveillance is adequate for the majority of patients with screen-detected colorectal polyp cancers. Consideration of segmental resection should be reserved for those with incomplete excision or evidence of lymphovascular invasion.</description><identifier>ISSN: 0017-5749</identifier><identifier>EISSN: 1468-3288</identifier><identifier>DOI: 10.1136/gutjnl-2016-312201</identifier><identifier>PMID: 27789658</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Algorithms ; Cancer ; Colorectal cancer ; Decision making ; Endoscopy ; Gastroenterology ; Intestine ; Lymph nodes ; Medical prognosis ; Medical screening ; Metastases ; Mortality ; Patients ; Population ; Surgical outcomes ; Surveillance ; Systematic review ; Tumors</subject><ispartof>Gut, 2018-02, Vol.67 (2), p.299-306</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing</rights><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.</rights><rights>Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b413t-3137a5f0f85715a85508051af38b971cd7f6d2655bfffe36b15808cc10f2bedb3</citedby><cites>FETCH-LOGICAL-b413t-3137a5f0f85715a85508051af38b971cd7f6d2655bfffe36b15808cc10f2bedb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27789658$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Richards, CH</creatorcontrib><creatorcontrib>Ventham, NT</creatorcontrib><creatorcontrib>Mansouri, D</creatorcontrib><creatorcontrib>Wilson, M</creatorcontrib><creatorcontrib>Ramsay, G</creatorcontrib><creatorcontrib>Mackay, CD</creatorcontrib><creatorcontrib>Parnaby, CN</creatorcontrib><creatorcontrib>Smith, D</creatorcontrib><creatorcontrib>On, J</creatorcontrib><creatorcontrib>Speake, D</creatorcontrib><creatorcontrib>McFarlane, G</creatorcontrib><creatorcontrib>Neo, YN</creatorcontrib><creatorcontrib>Aitken, E</creatorcontrib><creatorcontrib>Forrest, C</creatorcontrib><creatorcontrib>Knight, K</creatorcontrib><creatorcontrib>McKay, A</creatorcontrib><creatorcontrib>Nair, H</creatorcontrib><creatorcontrib>Mulholland, C</creatorcontrib><creatorcontrib>Robertson, JH</creatorcontrib><creatorcontrib>Carey, FA</creatorcontrib><creatorcontrib>Steele, RJC</creatorcontrib><creatorcontrib>Scottish Surgical Research Group</creatorcontrib><title>An evidence-based treatment algorithm for colorectal polyp cancers: results from the Scottish Screen-detected Polyp Cancer Study (SSPoCS)</title><title>Gut</title><addtitle>Gut</addtitle><description>ObjectivesColorectal polyp cancers present clinicians with a treatment dilemma. Decisions regarding whether to offer segmental resection or endoscopic surveillance are often taken without reference to good quality evidence. The aim of this study was to develop a treatment algorithm for patients with screen-detected polyp cancers.DesignThis national cohort study included all patients with a polyp cancer identified through the Scottish Bowel Screening Programme between 2000 and 2012. Multivariate regression analysis was used to assess the impact of clinical, endoscopic and pathological variables on the rate of adverse events (residual tumour in patients undergoing segmental resection or cancer-related death or disease recurrence in any patient). These data were used to develop a clinically relevant treatment algorithm.Results485 patients with polyp cancers were included. 186/485 (38%) underwent segmental resection and residual tumour was identified in 41/186 (22%). The only factor associated with an increased risk of residual tumour in the bowel wall was incomplete excision of the original polyp (OR 5.61, p=0.001), while only lymphovascular invasion was associated with an increased risk of lymph node metastases (OR 5.95, p=0.002). When patients undergoing segmental resection or endoscopic surveillance were considered together, the risk of adverse events was significantly higher in patients with incomplete excision (OR 10.23, p&lt;0.001) or lymphovascular invasion (OR 2.65, p=0.023).ConclusionA policy of surveillance is adequate for the majority of patients with screen-detected colorectal polyp cancers. Consideration of segmental resection should be reserved for those with incomplete excision or evidence of lymphovascular invasion.</description><subject>Algorithms</subject><subject>Cancer</subject><subject>Colorectal cancer</subject><subject>Decision making</subject><subject>Endoscopy</subject><subject>Gastroenterology</subject><subject>Intestine</subject><subject>Lymph nodes</subject><subject>Medical prognosis</subject><subject>Medical screening</subject><subject>Metastases</subject><subject>Mortality</subject><subject>Patients</subject><subject>Population</subject><subject>Surgical outcomes</subject><subject>Surveillance</subject><subject>Systematic review</subject><subject>Tumors</subject><issn>0017-5749</issn><issn>1468-3288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNqNkcFu1DAQhi1ERbeFF-CALHEphxQ7jmOHW7WCFqkSlQJny3bG3ayceLEdpH0E3hq3aTlw4jRz-L5fM_oRekvJJaWs_Xi_5P3sq5rQtmK0LvMF2tCmlRWrpXyJNoRQUXHRdKfoLKU9IUTKjr5Cp7UQsmu53KDfVzOGX-MAs4XK6AQDzhF0nmDOWPv7EMe8m7ALEdvgQwSbtceH4I8HbHWRYvqEI6TF54RdDBPOO8C9DTmPaVeWCDBXA-Qiluy7R3H7KOI-L8MRX_T9Xdj2H16jE6d9gjdP8xz9-PL5-_amuv12_XV7dVuZhrJcHmVCc0ec5IJyLTknknCqHZOmE9QOwrVD3XJunHPAWkO5JNJaSlxtYDDsHF2suYcYfi6QsprGZMF7PUNYkqKScUJY03YFff8Pug9LnMt1qiaNJIJ3jBWqXikbQ0oRnDrEcdLxqChRD0WptSj1UJRaiyrSu6foxUww_FWemylAtQJm2v9P4B9-TZ9F</recordid><startdate>201802</startdate><enddate>201802</enddate><creator>Richards, CH</creator><creator>Ventham, NT</creator><creator>Mansouri, D</creator><creator>Wilson, M</creator><creator>Ramsay, G</creator><creator>Mackay, CD</creator><creator>Parnaby, CN</creator><creator>Smith, D</creator><creator>On, J</creator><creator>Speake, D</creator><creator>McFarlane, G</creator><creator>Neo, YN</creator><creator>Aitken, E</creator><creator>Forrest, C</creator><creator>Knight, K</creator><creator>McKay, A</creator><creator>Nair, H</creator><creator>Mulholland, C</creator><creator>Robertson, JH</creator><creator>Carey, FA</creator><creator>Steele, RJC</creator><general>BMJ Publishing Group LTD</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>201802</creationdate><title>An evidence-based treatment algorithm for colorectal polyp cancers: results from the Scottish Screen-detected Polyp Cancer Study (SSPoCS)</title><author>Richards, CH ; Ventham, NT ; Mansouri, D ; Wilson, M ; Ramsay, G ; Mackay, CD ; Parnaby, CN ; Smith, D ; On, J ; Speake, D ; McFarlane, G ; Neo, YN ; Aitken, E ; Forrest, C ; Knight, K ; McKay, A ; Nair, H ; Mulholland, C ; Robertson, JH ; Carey, FA ; Steele, RJC</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b413t-3137a5f0f85715a85508051af38b971cd7f6d2655bfffe36b15808cc10f2bedb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Algorithms</topic><topic>Cancer</topic><topic>Colorectal cancer</topic><topic>Decision making</topic><topic>Endoscopy</topic><topic>Gastroenterology</topic><topic>Intestine</topic><topic>Lymph nodes</topic><topic>Medical prognosis</topic><topic>Medical screening</topic><topic>Metastases</topic><topic>Mortality</topic><topic>Patients</topic><topic>Population</topic><topic>Surgical outcomes</topic><topic>Surveillance</topic><topic>Systematic review</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Richards, CH</creatorcontrib><creatorcontrib>Ventham, NT</creatorcontrib><creatorcontrib>Mansouri, D</creatorcontrib><creatorcontrib>Wilson, M</creatorcontrib><creatorcontrib>Ramsay, G</creatorcontrib><creatorcontrib>Mackay, CD</creatorcontrib><creatorcontrib>Parnaby, CN</creatorcontrib><creatorcontrib>Smith, D</creatorcontrib><creatorcontrib>On, J</creatorcontrib><creatorcontrib>Speake, D</creatorcontrib><creatorcontrib>McFarlane, G</creatorcontrib><creatorcontrib>Neo, YN</creatorcontrib><creatorcontrib>Aitken, E</creatorcontrib><creatorcontrib>Forrest, C</creatorcontrib><creatorcontrib>Knight, K</creatorcontrib><creatorcontrib>McKay, A</creatorcontrib><creatorcontrib>Nair, H</creatorcontrib><creatorcontrib>Mulholland, C</creatorcontrib><creatorcontrib>Robertson, JH</creatorcontrib><creatorcontrib>Carey, FA</creatorcontrib><creatorcontrib>Steele, RJC</creatorcontrib><creatorcontrib>Scottish Surgical Research Group</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Gut</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Richards, CH</au><au>Ventham, NT</au><au>Mansouri, D</au><au>Wilson, M</au><au>Ramsay, G</au><au>Mackay, CD</au><au>Parnaby, CN</au><au>Smith, D</au><au>On, J</au><au>Speake, D</au><au>McFarlane, G</au><au>Neo, YN</au><au>Aitken, E</au><au>Forrest, C</au><au>Knight, K</au><au>McKay, A</au><au>Nair, H</au><au>Mulholland, C</au><au>Robertson, JH</au><au>Carey, FA</au><au>Steele, RJC</au><aucorp>Scottish Surgical Research Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An evidence-based treatment algorithm for colorectal polyp cancers: results from the Scottish Screen-detected Polyp Cancer Study (SSPoCS)</atitle><jtitle>Gut</jtitle><addtitle>Gut</addtitle><date>2018-02</date><risdate>2018</risdate><volume>67</volume><issue>2</issue><spage>299</spage><epage>306</epage><pages>299-306</pages><issn>0017-5749</issn><eissn>1468-3288</eissn><abstract>ObjectivesColorectal polyp cancers present clinicians with a treatment dilemma. Decisions regarding whether to offer segmental resection or endoscopic surveillance are often taken without reference to good quality evidence. The aim of this study was to develop a treatment algorithm for patients with screen-detected polyp cancers.DesignThis national cohort study included all patients with a polyp cancer identified through the Scottish Bowel Screening Programme between 2000 and 2012. Multivariate regression analysis was used to assess the impact of clinical, endoscopic and pathological variables on the rate of adverse events (residual tumour in patients undergoing segmental resection or cancer-related death or disease recurrence in any patient). These data were used to develop a clinically relevant treatment algorithm.Results485 patients with polyp cancers were included. 186/485 (38%) underwent segmental resection and residual tumour was identified in 41/186 (22%). The only factor associated with an increased risk of residual tumour in the bowel wall was incomplete excision of the original polyp (OR 5.61, p=0.001), while only lymphovascular invasion was associated with an increased risk of lymph node metastases (OR 5.95, p=0.002). When patients undergoing segmental resection or endoscopic surveillance were considered together, the risk of adverse events was significantly higher in patients with incomplete excision (OR 10.23, p&lt;0.001) or lymphovascular invasion (OR 2.65, p=0.023).ConclusionA policy of surveillance is adequate for the majority of patients with screen-detected colorectal polyp cancers. Consideration of segmental resection should be reserved for those with incomplete excision or evidence of lymphovascular invasion.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>27789658</pmid><doi>10.1136/gutjnl-2016-312201</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0017-5749
ispartof Gut, 2018-02, Vol.67 (2), p.299-306
issn 0017-5749
1468-3288
language eng
recordid cdi_proquest_miscellaneous_1835003469
source PubMed Central
subjects Algorithms
Cancer
Colorectal cancer
Decision making
Endoscopy
Gastroenterology
Intestine
Lymph nodes
Medical prognosis
Medical screening
Metastases
Mortality
Patients
Population
Surgical outcomes
Surveillance
Systematic review
Tumors
title An evidence-based treatment algorithm for colorectal polyp cancers: results from the Scottish Screen-detected Polyp Cancer Study (SSPoCS)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T15%3A49%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20evidence-based%20treatment%20algorithm%20for%20colorectal%20polyp%20cancers:%20results%20from%20the%20Scottish%20Screen-detected%20Polyp%20Cancer%20Study%20(SSPoCS)&rft.jtitle=Gut&rft.au=Richards,%20CH&rft.aucorp=Scottish%20Surgical%20Research%20Group&rft.date=2018-02&rft.volume=67&rft.issue=2&rft.spage=299&rft.epage=306&rft.pages=299-306&rft.issn=0017-5749&rft.eissn=1468-3288&rft_id=info:doi/10.1136/gutjnl-2016-312201&rft_dat=%3Cproquest_cross%3E1835003469%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2048075933&rft_id=info:pmid/27789658&rfr_iscdi=true